Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Walter Morton who wrote (2664)	3/22/2000 3:05:00 PM
From: Phil Cressman	Respond to of 2742

Walter, this is just about exactly what I figured was happening and why I sold out a month ago. Now the details are out I'm still underwhelmed. Considering the shares outstanding and the cheap options to be exercised yet I doubt shareholders will see 70 cents a share out of this deal and that in stock. It sure must have been a buyers market because they got Cistron and all that cash on the cheap.

To: Walter Morton who wrote (2664)	3/22/2000 3:19:00 PM
From: Chris W.	Read Replies (1) \| Respond to of 2742

If people are serious about wanting to reject the merger, we need to rally the support of the institutions. Last I knew, they owned significant chunks of CIST. I don't credit them with being too with it, so they will need some educating. I once tried to motivate them to get more involved by contacting them directly (I think I still have the contact info if anyone wants it). I would do it, but CIST has burnt me out over the years. Frankly, I am just happy to see some forward progress from these slugs.